Upload
april-lang
View
217
Download
0
Embed Size (px)
Citation preview
1
The concept for a network of national Reference Laboratories for high risk IVDs
–
Results of the working group meeting
Medical Devices Roadmap11.10.2010
2
Elements which may be considered.....
....“Ensuring uniform high standards and criteria for the conformity assessment by notified bodies, in particular as regards the assessment of the manufacturer's clinical evaluation and in the field of new technologies“
....“Alignment of the classification of IVDs with GHTF guidance”
Main problems identified....
.....“The key elements to the framework are Market Surveillance, Vigilance, Notified Bodies,Clinical Evaluation and Transparency. These areas have suffered in terms of coherence anduniformity of approach in particular due to the lack of efficient coordination between theMember States.“
.....“New and emerging technologies have challenged the current framework, highlighting gaps or pointing to potential loopholes including the scarcity of expertise needed to independently assess such technologies. The framework needs to fill these gaps and be made more robust to future technologies.“
3
Concept for a network of national Reference Laboratories for high risk IVDs
27th Meeting of the CAMD Budapest, 24-25. February, 2011Presentation by M. Funk
→ Working Group for further Elaboration
4
Concept for a network of national Reference Laboratories for high risk IVDs
Working Group MeetingLangen, 27. June, 2011
Participants: FR, UK, IR, DEDG Sanco, Joint Research Centre (JRC)
IVD Technical GroupBrussels, 15. September, 2011Task Force Ref Lab Network: BE, FR, UK, DE; JRC
→ Concept Paper “Plan for a network...”
5
• Current situation
Manufacturers and Notified Bodies estimate...
...Risk – benefit ratio
...Compliance with „state of the art“
Fulfillment of CTS as indication of „state of the art“,
but...
...Most NBs need external expertise
...GHTF class D may include IVDs without CTS
Concept for a network of national Reference Laboratories for high risk IVDs
6
Conformity Assessment of High Risk Devices
IVD-Manufacturer Notified BodyQS Annex IV, 3
DE Annex IV, 4
BV Annex IV, 6
QS Quality SystemDE Design Examination BV Batch Verification
1234
7
• Network of Reference Laboratories
– Uniform determination of „state of the art“
– Boost the trust of users and patients
– Benefit for IVD industry
– Good experience with EU Reference Laboratories in the food sector
Concept for a network of national Reference Laboratories for high risk IVDs
8
• Tasks of Reference Laboratories (RL) Network
Pre-Market
– NB uses a RL within the Network for high risk devices (GHTF D)
• Experimental Pre-market assessment of key aspects
• Batch verification
Concept for a network of national Reference Laboratories for high risk IVDs
9
IVD-Manufacturer Notified Body
Reference Laboratory
QS Annex IV, 3
DE Annex IV, 4
BV Annex IV, 6
QS Quality SystemDE Design Examination BV Batch Verification
Experimental assessment of key performance aspects
Pre-market assessment
Concept for a network of national Reference Laboratories for high risk IVDs
10
Experimental assessment of key performance aspects
• Sensitivity / specificity
diagnostic sensitivity of serological blood screening assaysanalytical sensitivity of NAT blood screening assaysviral genotype inclusivity(accuracy of genetic tests, GHTF D?)
• Same pre-agreed specimens / panels within the Network
• Common data basis for CE-marked devices: „state of the art“
RL issues report on experimental assessment to NB
Concept for a network of national Reference Laboratories for high risk IVDs
→ Within RL Network: overview of “state of the art”
11
IVD-Manufacturer Notified Body
Reference Laboratory
QS Annex IV, 3
DE Annex IV, 4
BV Annex IV, 6
QS Quality SystemDE Design Examination BV Batch Verification
Batch Verification
Concept for a network of national Reference Laboratories for high risk IVDs
Pre-market assessment
12
Batch verification
The aim is an EU-uniform procedure
RL performs verification of new batches according to uniform pre-agreed criteria
frequency of verification testing
extent and focus of verification testing
common verification criteria
modalities of verification testing
RL issues batch verification test report to NB
Concept for a network of national Reference Laboratories for high risk IVDs
13
• Tasks of Reference Laboratories (RL) Network
Post-Market
Concept for a network of national Reference Laboratories for high risk IVDs
Reference Laboratories Network: source of expertise
to advise the European Commissionon CTS for new high-risk devices (GHTF, D?)on regular updating of the CTS on safeguard clauseson evolving technologies, emerging pathogens, ...
to support Competent Authoritiesin the estimation of incident reportsby offering experimental studiesby providing support for market surveillance by determining the „state of the art“
14
• Requirements for national Reference Laboratory
– Proven expertise
• assessment of GHTF class D devices• testing or calibration laboratory• developing reference materials• participating in external quality assessment schemes (EQAS) • scientific publications
– Sufficient ressources
– Certified QM system (e.g. ISO EN 17025; 98/79/EC)
– International cooperation, information exchange
Concept for a network of national Reference Laboratories for high risk IVDs
15
• Requirements for the Reference Laboratories Network
– Applying coordinated methods, procedures and processes
– Using the same reference materials and applying common evaluation methods
– Establishment of common assessment criteria
– Close cooperation within the network (joints guidelines, SOPs, harmonised approach within the network)
– Coordinating Body
Concept for a network of national Reference Laboratories for high risk IVDs
16
Conformity Assessment of High Risk Devices
IVD-Manufacturer
Reference Laboratories Network
Notified Body
Coordinating Body
QS Annex IV, 3
DE Annex IV, 4
BV Annex IV, 6
QS Quality SystemDE Design Examination BV Batch Verification
17
• Legal basis
• Reference Laboratories Network should be legally enshrined within the Directive
• Coordinating body should be defined by the Directive
• Defined minimum criteria (Directive / Committee / implementing acts)
• Competent Authority of the Member State: recognition and supervision of national Reference Laboratory
Concept for a network of national Reference Laboratories for high risk IVDs
18
• Financial aspects
• Additional costs should be within manageable range
• External expertise already now used by NBs for assessment and batch verification
• Integration of the reference laboratory network into existing frame (DG Joint Research Centre of the European Commission) ?
Concept for a network of national Reference Laboratories for high risk IVDs
19
Concept of IVD Reference Laboratories....
.... addresses deficiencies of current IVD system identified in the Road Map
.... provides specialised IVD expertise to cope with IVD challenges
.... enables assessment of evolving new technologies by experts
.... counteracts decreasing governmental IVD expertise
Concept for a network of national Reference Laboratories for high risk IVDs
20
Thank you for your attention !